Chronic Kidney Disease Archives - Page 3 of 4 - MPR

Chronic Kidney Disease

New Indication: Invokana

Invokana is now approved to reduce the risk of end-stage renal disease, doubling of serum creatinine, cardiovascular death, and hospitalization for heart failure in adults with type 2 diabetes and diabetic nephropathy with albuminuria >300mg/day.